Reevaluation Of Systemic Early Neuromuscular Blockade
NCT02509078
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1008
Enrollment
OTHER
Sponsor class
Conditions
Acute Respiratory Distress Syndrome
Interventions
DRUG:
Cisatracurium Besylate
Sponsor
Massachusetts General Hospital
Collaborators
[object Object]